Tumor-suppressor Gene Promoter Hypermethylation in Saliva of Head and Neck Cancer Patients

Translational Oncology

Volumn 5, Issue 5, 2012, Pages 321-326

  Ovchinnikov, Dmitry A ^a   Cooper, Matthew A ^a   Pandit, Pratibala ^a   Coman, William B ^a   Cooper White, Justin J ^a   Keith, Patricia ^a   Wolvetang, Ernst J ^a   Slowey, Paul D ^b   Punyadeera, Chamindie ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Oasis Diagnostics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DEATH ASSOCIATED PROTEIN KINASE; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ACCURACY; ADULT; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DNA ISOLATION; DNA METHYLATION; FEMALE; FISHER EXACT TEST; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SMOKING; TUMOR SUPPRESSOR GENE;

EID: 84867510706     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.12232     Document Type: Article

References (26)

1. Brinkmann O, Kastratovic DA, Dimitrijevic MV, Konstantinovic VS, Jelovac DB, Antic J, Nesic VS, Markovic SZ, Martinovic ZR, Akin D, et al. (2011). Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol 47, 51-55.
2. Wu JY, Yi C, Chung HR, Wang DJ, Chang WC, Lee SY, Lin CT, Yang YC, and Yang WC (2010). Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol 46, 226-231.
3. Freedman ND, Abnet CC, Leitzmann MF, Hollenbeck AR, and Schatzkin A (2007). Prospective investigation of the cigarette smoking-head and neck cancer association by sex. Cancer 110, 1593-1601.
4. WHO (2008). WHO Report. http://www.who.int/whosis/indicators/compendium/ 2008/2ptu/en/index.html.
5. Viet CT and Schmidt BL (2008). Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol Biomarkers Prev 17, 3603-3611.
6. Richards KL, Zhang B, Baggerly KA, Colella S, Lang JC, Schuller DE, and Krahe R (2009). Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS One 4, e4941.
7. Smith IM, Mydlarz WK, Mithani SK, and Califano JA (2007). DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int J Cancer 121, 1724-1728.
8. Herman JG and Baylin SB (2003). Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349, 2042-2054.
9. Jones PA and Baylin SB (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3, 415-428.
10. Fan CY (2004). Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications. Curr Oncol Rep 6, 152-161.
11. Shaw R (2006). The epigenetics of oral cancer. Int J Oral Maxillofac Surg 35, 101-108.
12. Punyadeera C (2012). Human saliva as a tool to investigate intimate partner violence. Brain Behav Immun 26, 541-542.
13. Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, and Nagler RM (2007). Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer 109, 54-59.
14. Punyadeera C, Dimeski G, Kostner K, Beyerlein P, and Cooper-White J (2011). One-step homogeneous C-reactive protein assay for saliva. J Immunol Methods 373, 19-25.
15. Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, and Punyadeera C (2011). Diagnostic potential of saliva: current state and future applications. Clin Chem 57, 675-687.
16. Topkas E, Keith P, Dimeski G, Cooper-White J, and Punyadeera C (2012). Evaluation of saliva collection devices for the analysis of proteins. Clin Chim Acta 413, 1066-1070.
17. Schulz BL, Cooper-White J, and Punyadeera CK (2012). Saliva proteome research: current status and future outlook. Crit Rev Biotechnol [E-pub ahead of print 21 May].
18. Righini CA, de Fraipont F, Timsit JF, Faure C, Brambilla E, Reyt E, and Favrot MC (2007). Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res 13, 1179-1185.
19. Righini CA, de Fraipont F, Reyt E, and Favrot MC (2007). Aberrant methylation of tumor suppressor genes in head and neck squamous cell carcinoma: is it clinically relevant? Bull Cancer 94, 191-197.
20. INK4ain primary rat lung tumors. Mol Cell Biol 17, 1366-1374.
21. INK4agenes in the development of mouse lung tumors. Exp Lung Res 24, 463-479.
22. Lee YW, Klein CB, Kargacin B, Salnikow K, Kitahara J, Dowjat K, Zhitkovich A, Christie NT, and Costa M (1995). Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol 15, 2547-2557.
23. INK4aand histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 61, 3419-3424.
24. Wild D (2001). The Immunoassay Handbook. Nature Publishing Group, New York, NY. p. 906.
25. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, and Belinsky SA (2000). Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60, 5954-5958.
26. Esteller M, Corn PG, Baylin SB, and Herman JG (2001). A gene hypermethylation profile of human cancer. Cancer Res 61, 3225-3229.